Screener
GeneDx Holdings WGS Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | March 31, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $93,924 | $104,997 |
| Marketable securities | 76,761 | 66,285 |
| Accounts receivable | 76,929 | 74,370 |
| Inventory, net | 12,241 | 13,951 |
| Prepaid expenses and other current assets | 10,774 | 8,685 |
| Total current assets | 270,629 | 268,288 |
| Operating lease right-of-use assets | 34,653 | 23,412 |
| Property and equipment, net | 50,125 | 45,693 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's inventories?
- GeneDx Holdings (WGS) reported inventories of $12.24M in Q1 2026.
- How has GeneDx Holdings's inventories changed year-over-year?
- GeneDx Holdings's inventories decreased by 3.3% year-over-year, from $12.66M to $12.24M.
- What is the long-term trend for GeneDx Holdings's inventories?
- Over 4 years (2021 to 2025), GeneDx Holdings's inventories has grown at a -21.1% compound annual growth rate (CAGR), from $126.73M to $49.11M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about GeneDx Holdings's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude